Scotland demonstrates its collaborative approach to cell therapy development
Released: Monday 21st October 2013
Collaborations with Roslin Cells and QCMD set to give Sistemic lead in cell characterisation standardisation and make Scotland key destination for cell therapy clinical trials
Scottish Development International and leading industry players, Sistemic and Roslin Cells, are committed to linking cell therapy clinical trials to the most up-to-date technologies to drive wider adoption of the ground-breaking field.
Full Release: Click to read the full release